Metabolic · ~3 min read
Retatrutide: What It Is, How It Works & What the Research Shows
Overview
Retatrutide (LY3437943) is an investigational triple agonist that activates GIP, GLP-1 and glucagon receptors in a single molecule. The incretin activity reduces appetite and improves glucose control, while glucagon receptor activity is thought to raise energy expenditure and liver fat burning. In a 2023 phase 2 trial published in NEJM, the 12 mg arm produced a 24.2% mean weight reduction at 48 weeks, the largest seen with any obesity drug at that point. Phase 3 trials are evaluating it for obesity, diabetes and related conditions.
Why researchers study it
Weight loss
Up to 24% average weight loss at 48 weeks in phase 2.
Blood sugar control
Improved HbA1c and glucose in type 2 diabetes trials.
Liver fat
Produced large reductions in liver fat in phase 2 substudies.
How it works
Investigational triple receptor agonism combines incretin signaling with glucagon-receptor activity. Research examines appetite, glucose regulation and energy metabolism.
Adamantane & the blood–brain barrier
Chemically attaching an adamantane group to a peptide can increase its lipid (fat) solubility. Researchers hypothesize that this modification may help certain compounds cross the tightly regulated blood–brain barrier. The effect depends on the specific modified molecule; greater lipid solubility alone does not establish brain delivery or clinical benefit. This does not apply automatically to the unmodified peptide and is not a reconstitution additive.
What the research shows
- A phase 2 trial evaluated weight reduction in adults with obesity or overweight and a weight-related condition.
- Combined GIP, GLP-1 and glucagon receptor activation is an investigational metabolic research target.
Typical protocol
Reconstitute a 10 mg vial with 1 mL bacteriostatic water for 10 mg/mL. Typical range: 0.5–12 mg 1x daily · 1–2x weekly (split dose), As long as needed.
Common stacks
- Retatrutide + BPC-157 — The supplied reference proposes gastrointestinal protection.
- Retatrutide + Ipamorelin — The supplied reference proposes preservation of lean mass during weight loss.
Potential benefits & side effects
Potential benefits
- Significant reduction in appetite and food noise
- Clinically meaningful weight loss
- Improved blood sugar and insulin sensitivity
- Improvements in blood pressure, lipids and liver fat
Side effects
- Nausea, vomiting, diarrhea or constipation (most common, usually during dose increases)
- Reduced appetite to the point of under-eating
- Fatigue and occasional headache
- Increased heart rate (especially triple/glucagon agonists)
- Rare: gallbladder problems or pancreatitis — seek care for severe abdominal pain
Lifestyle factors
- Protein: aim for adequate protein (about 0.7–1 g per lb of goal body weight) to preserve muscle during weight loss.
- Resistance training: lift 2–4x per week to protect lean mass.
- Hydration & fiber: drink plenty of water and eat fiber to reduce constipation and nausea.
- Meal size: eat smaller meals and stop at fullness; greasy, heavy meals worsen GI side effects.
- Titrate slowly: stay at a dose until side effects settle before increasing.